8:30AM - 10:35AM
Friday, 10th February
CSL Lecture Theatre
10:35AM - 11:00AM
Friday, 10th February
Exhibition Hall
11:00AM - 1:00PM
Friday, 10th February
CSL Lecture Theatre
12:55PM - 4:00PM
Friday, 10th February
Exhibition Hall
2:00PM - 3:00PM
Friday, 10th February
Heritage 3
3:00PM - 4:00PM
Friday, 10th February
CSL Lecture Theatre
4:00PM - 6:30PM
Friday, 10th February
CSL Lecture Theatre
6:30PM - 7:30PM
Friday, 10th February
Seagrass Lawn
7:30PM - 10:00PM
Friday, 10th February
Exhibition Hall
-
Single Cell Cisplatin Measurements by ICP-MS -
Chuang Fongu Dr. Kong
-
New patient-derived xenograft models of lethal prostate cancer -
Mitchell Lawrence
-
Structural biology of Scribble, a cell polarity regulator and tumour suppressor protein -
Krystle YB Lim
-
Plasma biomarkers of response to immune therapy in melanoma -
Su Yin Lim
-
Phase 2 study of circulating microRNA biomarkers in metastatic prostate cancer -
Hui-Ming Lin
-
FAK inhibitor VS-6063 enhances docetaxel chemotherapy efficacy in prostate cancer -
Hui-Ming Lin
-
Modulation of PD-1 and PD-L1 expression in myeloid malignancies: Evidence for potential biomarker evaluation of resistance to epigenetic therapy -
Hongbin Liu
-
Understanding the Role of Pro-inflammatory Cytokines in the Development of Gastric Cancer -
Jun Ting Low
-
The thioredoxin, glutathione and DJ-1 antioxidant systems as potential therapy targets in lymphoma cells -
Yaoying Lu
-
Pre-clinical evaluation of small molecule LOXL2 inhibitors in breast cancer -
Morghan C Lucas
-
The EHF transcription factor is downregulated in poorly differentiated colorectal cancers and inhibits cell migration -
Ian Y Luk
-
Exosomes derived from Glioma Stem Cells (GSCs) promote cell migration, proliferation and radiation resistance in brain cancer. -
Chenkai Ma
-
Development of a therapeutic modality for the specific treatment of EpCAM positive brain metastases -
Joanna Macdonald
-
The role of ZYG11 family members in development and disease -
Charlene Magtoto
-
Single cell tracking to study the phenotypic effects of cytoplasmic exchange between fibroblasts and osteosarcoma cells -
Swarna Mahadevan
-
Phase II trial of circulating cytokines as markers of docetaxel resistance in metastatic castrate-resistant prostate cancer (mCRPC). -
Kate Mahon
-
Demibodies for highly specific cell detection and killing -
Athina Manakas
-
A computational tool for deconvolving cell type specific transcriptomes from tumor microenvironment mixtures -
Stefano Mangiola
-
Developing Kadcyla™ as a novel therapy for a subset of triple negative breast cancer patients -
Mariam Mansour
-
Anti-cancer properties of interferon epsilon (IFNε) -
Zoe Marks
-
CTCF Genetic Alterations in Endometrial Carcinoma are Functionally Pro-tumorigenic -
Amy D Marshall
-
Dual CDK4 and BRAF inhibitor therapy in melanoma: tumour intrinsic and microenvironment effects -
Claire Martin
-
Recovery of non-small cell lung cancer cultured cells from blood by ClearCell FX microfluidic label-free separation system vs. RosetteSep CTC enrichment cocktail -
Joel Mason
-
Natural Killer Cells Require Heparanase For Effective Function and Migration -
Alyce Mayfosh
-
Exploiting doxorubicin-DNA adducts in metastatic breast cancer models -
Sean C McGrath
-
Loss of T-ALL tumour suppressor PHF6 enhances haematopoietic stem cell differentiation without compromising self-renewal -
Helen McRae
-
Targeting chemokine signaling in breast cancer -
Albert S Mellick
-
Mucosal Associated Invariant T-Cells (MAIT) - Companions or conspirators within the tumour microenvironment? -
Rosemary Millen
-
CANCER 2015: A Prospective, Population-based Cancer Genome Cohort -
So Young Moon
-
Combination therapy of the Smac-mimetic birinapant and clinically relevant compounds to overcome resistance in the treatment of acute myeloid leukaemia -
Emma Morrish
-
Targeting focal adhesion kinase activity in pancreatic cancer -
Kendelle Murphy
-
MicroRNA-211 - A Novel Oncogene in Acute Myeloid Leukemia -
Nisha Narayan
-
Uncovering mechanisms of PARP inhibitor resistance in high-grade serous ovarian carcinoma patient-derived xenografts -
Ksenija Nesic
-
Subclonal mutation rate as a marker of risk of invasion in colorectal adenomas -
Benedict Ng
-
PATZ1 regulates cell proliferation in liver cancer by the direct regulation of CDKN1B -
Zhen Long Ng
-
Systems analysis of the EGFR-PYK2-cMet interaction network identifies synergistic drug combinations and predicts individualised patient response in triple-negative breast cancer -
Lan K Nguyen
-
Loss of the RNA transporter Sidt2 inhibits tumour development -
Tan A Nguyen
-
Altered esophageal microbiome in Barrett’s esophagus and esophageal adenocarcinoma -
Thi-My-Tam Nguyen
-
Synthetic CRISPRs: Novel Approaches to Study Gene Function -
Iva Nikolic
-
A RhoA-FRET biosensor mouse for intravital imaging in normal tissue homeostasis and disease contexts. -
Max Nobis
-
The extracellular pH of the microenvironment modulates the cytotoxicities of mitochondrial inhibitors against melanoma -
Fumihito FN Noguchi
-
MCL-1 inhibition provides a new way to suppress breast cancer metastasis and increase sensitivity to dasatinib. -
Samantha Oakes
-
Quantitative phosphoproteomics of patient-derived primary cells reveals a druggable CDK7 signature in ovarian cancer -
Jesper V. Olsen
-
Identification of clinically relevant colon cancer genes predictive of improved relapse free survival -
Marie Parsons
-
UNRAVELLING THE CLINICAL RELEVANCE OF BREAST CANCER CELL PLASTICITY IN TUMOUR DEVELOPMENT AND METASTASIS -
Beatriz Perez San Juan
-
Exploring the expressional landscape of patient-derived metastatic cutaneous squamous cell carcinoma cell models -
Jay R Perry
-
Establishing a histopathologically validated patient derived xenotransplant model of head and neck cancer -
Rachael Pillay
-
E6AP negatively regulates p27 expression to promote prostate cancer -
Dinesh Raghu
-
Delivery of humidified-warm carbon dioxide during open surgery ameliorates damage and hypoxia while accelerating wound healing in mice -
Rob Ramsay
-
Investigating the in vivo role of the EHF transcription factor in intestinal epithelial differentiation -
Camilla Reehorst
-
Size Distribution, Yield, and NGS Library Metrics for cfDNA and cfRNA Extracted from Different Donors, Different Body Fluids, and at Different Time-points -
Nandor Roczo
-
Single-cell transcriptomics reveals functional heterogeneity in breast cancer -
Daniel L Roden
-
Advancing a Myb DNA vaccine in the context of myb-dependent hematopoietic malignancies -
Sara Roth
-
Triterpenoid micellar nanoparticles: Potential inhibition of the PI3K/Akt signalling pathway for the treatment of glioblastoma -
Rebecca H Roubin
-
Exploring the role of the WNT-binding receptor tyrosine kinase RYK in cancer, with a focus on melanoma and lung squamous cell carcinoma -
James P Roy
-
Monitoring patient response to chemotherapy using exosomal DNA -
Olivia Ruhen
-
Systematic identification of dysregulated microRNAs in soft-tissue sarcomas through integrative expression analysis -
Regina Ryan
-
Exosomes from bovine milk reduces the tumor burden and attenuates cancer cachexia -
Monisha Samuel
-
Examining the potential of targeting ribosome biogenesis as a novel therapeutic strategy for ovarian cancer -
Elaine Sanij
-
MiR-137 acts as a tumour suppressor by targeting the oncoprotein YB1 in malignant pleural mesothelioma -
Karin Schelch
-
Determining the role of the pro-survival BCL-2 family member A1/BFL-1 in cancer -
Robyn L Schenk
-
The contribution of Epstein-Barr virus towards apoptotic resistance in extra-nodal NK/T cell lymphoma -
Nenad Sejic
-
Highly Accurate Genetic Profiling of Circulating Tumor Cells using a Label-free Inertial Microfluidic Approach Coupled with Droplet PCR-based Next-Generation Sequencing -
Tetyana Shandala
-
The role of periostin in tumour cell migration, apoptosis, invasion and proliferation in vitro -
Lynda A Sharp
-
A detailed functional assessment of mutations in BCL2 that could undermine therapeutic targeting with Venetoclax -
Eric Si
-
Targeting metabolic reprogramming in BRAFV600E melanoma -
Lorey Smith
-
Targeting rDNA chromatin by BRD4 inhibition as a highly effective therapeutic strategy for synergistic checkpoint activation by Pol I inhibitor CX-5461 in acute myeloid leukaemia -
Jirawas Sornkom
-
Investigating the interplay between oncogenic RAS, autophagy and oxidative stress in epithelial tumourigenesis -
Rebecca Stephens
-
New clinically relevant patient-derived xenograft models of medulloblastoma and preclinical evaluation of novel drug combinations -
Brooke S. Strowger
-
AMPylation of the UPR in melanoma -
Erin Sykes
-
Prospective isolation of normal melanocyte subpopulations from human and mouse skin -
Pacman Szeto
-
Targeting Myeloid Cell Leukaemia 1 in Mixed Lineage Leukaemia driven acute myeloid leukaemia -
Izabela Todorovski
-
Competing Risks Analysis of Microsatellite Instability as a Prognostic Factor in Colorectal Cancer -
Wei Tatt Toh
-
Histone deacetylase and proteasome inhibitors synergistically induce apoptosis through the enhanced induction ATF3. -
Janson W.T Tse
-
Distribution of BTN2A1 in Cancer and Potential Target for Immunotherapy -
Candani Tutuka
-
Emi1 overexpression promotes chromosomal instability and cancer -
Srividya Vaidyanathan
-
Frizzled7 functions as a Wnt receptor in gastrointestinal epithelial stem cells: implications for cancer growth and progression -
Elizabeth Vincan
-
Role of human arylamine N-acetyltransferase 1 in cancer cell metabolism -
lili wang
-
Phenotypic cell proliferation assay with Long term cell culture models to identify predictive biomarkers of response for oncology therapeutics -
Usha Warrior
-
FGFR inhibition increases cisplatin sensitivity in patient-derived xenografts of lung squamous cell carcinoma -
Clare E Weeden
-
STAT3 and sex in medulloblastoma -
Christine L White
-
Chemosensitisation of medulloblastomas using cell cycle checkpoint kinase inhibitors – a preclinical study -
Jacqueline Whitehouse
-
Systematic approach to methylation biomarker development in chronic lymphocytic leukemia, breast and lung cancers -
Tomasz K Wojdacz
-
Circulating tumor DNA analysis and functional imaging provide complementary approaches for comprehensive disease monitoring in metastatic melanoma -
Stephen Q Wong
-
Inflammation mediates profound changes to the immunopeptidome of melanoma -
Katherine Woods
-
Defining the relationship between RET and cancer biomarkers -
Xin Xiong
-
Cancer genetic mutation profiling in Cancer 2015 cohort -
Huiling Xu
-
A Genome-wide RNAi Screen Identifies Synthetic Lethality of CX-5461 with Homologous Recombination Repair Deficiency in Ovarian Cancer -
Shunfei Yan
-
Developing microRNA therapeutics for the treatment of triple negative breast cancer -
Jessica Yang
-
Inhibition of human ABC transporter ABCB1 sensitizes liver cancer stem cells to doxorubicin -
Wang Yin
-
Radiotherapy improves DNA repair efficiency in peripheral blood lymphocytes of patients with non-small cell lung cancer (NSCLC) -
Xiaoyu Sherry Yin
-
A prospective multi-center Phase III validation study of AZGP1 as a biomarker in localised prostate cancer -
Alison Y Zhang
-
Metabolism and Ribosome Biogenesis in Oncogene-Induced Senescence -
HAORAN ZHU
-
Malignant cell phenotype is changed by uptake of fibroblast contents via filopodia -
Hans Zoellner